TrialVaccine2023

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost.

Woo Joo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.